Evaluation of the dual mTOR/PI3K inhibitors Gedatolisib (PF-05212384) and PF-04691502 against ovarian cancer xenograft models

References

Page 1

	Year	Citations
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Jacques Ferlay, Hai‐Rim Shin, Freddie Bray, International Journal of Cancer Cancer ManagementEpidemiology Of CancerWorldwide IncidencePathologyCancer Registration	2010	21.3K
Integrated genomic analyses of ovarian carcinoma Debra Bell, Andrew Berchuck, Wendy Winckler Nature Tumor HeterogeneityGynecologyCancer GenomicsOvarian CarcinomaMolecular Diagnostics	2011	8K
Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex Dos D. Sarbassov, David A. Guertin, Siraj M. Ali, Science Molecular BiologyTumor BiologySignaling PathwayAkt/pkb ActivationReceptor Tyrosine Kinase	2005	6.1K
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt Kathryn O’Reilly, F. Rojo, Qing‐Bai She, Cancer Research	2006	2.5K
Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation Michael J. Hendzel, Wei Yi, Michael A. Mancini, Chromosoma ChromatinHistone H3Pericentromeric HeterochromatinCell DivisionMitotic Chromosome Condensation	1997	1.9K
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer Arkaitz Carracedo, Li Ma, Julie Teruya‐Feldstein, Journal of Clinical Investigation	2008	1.4K
The PTEN–PI3K pathway: of feedbacks and cross-talks Arkaitz Carracedo, Pier Paolo Pandolfi Oncogene Pten–pi3k PathwaySignal TransductionSignaling PathwayMolecular PathwayCellular Biochemistry	2008	884
AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth Deborah A. Altomare, Hui Qin Wang, Kristine L. Skele, Oncogene Mtor PhosphorylationMedicineCancer GrowthGynecologyCell Biology	2004	417
The biology of ovarian cancer. Nelly Auersperg, Mitchell I. Edelson, Samuel C. Mok, PubMed	1998	226
Bis(morpholino-1,3,5-triazine) Derivatives: Potent Adenosine 5′-Triphosphate Competitive Phosphatidylinositol-3-kinase/Mammalian Target of Rapamycin Inhibitors: Discovery of Compound <b>26</b> (PKI-587), a Highly Efficacious Dual Inhibitor Aranapakam M. Venkatesan, Christoph M. Dehnhardt, Efren Delos Santos, Journal of Medicinal Chemistry	2010	210

Page 1